000 | 01339 a2200373 4500 | ||
---|---|---|---|
005 | 20250517052822.0 | ||
264 | 0 | _c20160725 | |
008 | 201607s 0 0 eng d | ||
022 | _a1744-7674 | ||
024 | 7 |
_a10.1517/13543776.2015.1089233 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMusumeci, Francesca | |
245 | 0 | 0 |
_aAnalogs, formulations and derivatives of imatinib: a patent review. _h[electronic resource] |
260 |
_bExpert opinion on therapeutic patents _c2015 |
||
300 |
_a1411-21 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 | _aBiological Availability |
650 | 0 | 4 |
_aChemistry, Pharmaceutical _xmethods |
650 | 0 | 4 | _aDrug Design |
650 | 0 | 4 |
_aFusion Proteins, bcr-abl _xantagonists & inhibitors |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImatinib Mesylate _xadministration & dosage |
650 | 0 | 4 | _aNanoparticles |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 | _aPatents as Topic |
700 | 1 | _aSchenone, Silvia | |
700 | 1 | _aGrossi, Giancarlo | |
700 | 1 | _aBrullo, Chiara | |
700 | 1 | _aSanna, Monica | |
773 | 0 |
_tExpert opinion on therapeutic patents _gvol. 25 _gno. 12 _gp. 1411-21 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1517/13543776.2015.1089233 _zAvailable from publisher's website |
999 |
_c25264046 _d25264046 |